Company news
Bioasis Technologies Inc. news in 2018
Bioasis Technologies Inc.'s news releases, calls and decks from 2018, newest first.
Bioasis to Present at Investor & Industry Conferences in January 2019
December 13, 2018
Bioasis Appoints Dr. Deborah A. Rathjen as Executive Chair of the Board of Directors
December 10, 2018
Bioasis Announces Voting Results for 2018 Annual and Special Meeting
November 26, 2018
Bioasis Announces Positive Results from Peripheral Whole-Body PET/CT Scan Study in Non-Human Primates with Lead Investigational Candidate xB3-001TM
November 20, 2018
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2018
October 30, 2018
Bioasis Announces xB3 ™ Platform Technology Licensing Agreement with Prothena
October 29, 2018
Bioasis Announces Investor Relations Service Agreement with Stern IR
October 4, 2018
Aeromics, Inc. Appoints Pharmaceutical and Biotech Veterans Mark Day, Ph.D. and Thomas Zindrick, J.D. to Its Board of Directors
August 16, 2018
Bioasis Announces Closing of Previously Disclosed Private Placement
August 13, 2018
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending May 31, 2018
July 30, 2018
Bioasis Welcomes John E. Curran & David M. Wurzer to the Company’s Board of Directors
July 27, 2018
Bioasis Announces Positive Results from a Microdialysis Study Showing Lead Investigational Candidate xB3 ™-001 Increased Brain Activity
July 25, 2018
Bioasis Announces Non-Brokered Private Placement
July 15, 2018
Bioasis Announces Non-Brokered Private Placement
July 16, 2018
Bioasis and BioAgilytix Announce Strategic Collaboration to Advance xB3 TM-001, Bioasis’ Lead Investigational Candidate to Treat HER2+ Brain Cancer, to IND Submission and into the Clinic
July 11, 2018
Bioasis Further Strengthens Scientific Advisory Board with Addition of Dr. Mario Saltarelli, Dr. Jack Hoppin and Dr. Sue O’Connor
June 12, 2018
Bioasis Announces Publication of Independent Validation of the Company’s xB3 ™ Platform Technology
May 30, 2018
Uptick Newswire’s “Stock Day” Podcast Welcomes Dr. Mark Day of Bioasis Technologies Inc.
May 29, 2018
Bioasis Announces Closing of Second Tranche of Previously Disclosed Private Placement
May 24, 2018
Bioasis and WuXi Biologics Announce Initial Strategic Collaboration for the Development and Manufacturing of xB3-001, the Company’s Lead Investigational Candidate to Treat Brain Cancer
May 21, 2018
Bioasis Announces Closing of First Tranche of Previously Disclosed Private Placement
May 17, 2018
Bioasis Announces Private Placement and Intention to Pursue NASDAQ Listing
May 14, 2018
Bioasis Announces Key Strategic Appointment to its Senior Leadership Team with Addition of Caroline Hill, Ph.D., Leading Research & Development Operations
March 26, 2018
Bioasis Appoints Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE as Chair of the Board of Directors
March 21, 2018
Bioasis to Present at the 20th Annual BIO CEO & Investor Conference
February 6, 2018
Bioasis Announces Filing of Quarterly Financial Statements and MD&A
January 30, 2018